Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulseTM technology using proprietary nanosecond pulsed field ablation (nsPFATM) energy, today announced plans to participate in the upcoming Goldman Sachs 47 th Annual Global Healthcare Conference in Miami Beach, FL.